Skip to main content
AngioDynamics, Inc. (ANGO)
NASDAQ: ANGO · Real-Time Price · USD
13.47
-0.15 (-1.10%)
At close: Dec 5, 2025, 4:00 PM EST
13.32
-0.15 (-1.14%)
After-hours: Dec 5, 2025, 6:01 PM EST

AngioDynamics Revenue

AngioDynamics had revenue of $75.71M in the quarter ending August 31, 2025, with 12.18% growth. This brings the company's revenue in the last twelve months to $300.72M, up 2.73% year-over-year. In the fiscal year ending May 31, 2025, AngioDynamics had annual revenue of $292.50M, down -3.76%.

Revenue (ttm)
$300.72M
Revenue Growth
+2.73%
P/S Ratio
1.84
Revenue / Employee
$445,508
Employees
675
Market Cap
554.96M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
May 31, 2025292.50M-11.42M-3.76%
May 31, 2024303.91M-34.84M-10.28%
May 31, 2023338.75M22.53M7.13%
May 31, 2022316.22M25.21M8.66%
May 31, 2021291.01M26.85M10.17%
May 31, 2020 Pro Pro Pro
May 31, 2019 Pro Pro Pro
May 31, 2018 Pro Pro Pro
May 31, 2017 Pro Pro Pro
May 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 435.16B
Johnson & Johnson 92.15B
Merck & Co. 64.24B
AbbVie 59.64B
Eli Lilly and Company 59.42B
AstraZeneca 58.13B
Novartis AG 56.37B
Novo Nordisk 49.58B
Revenue Rankings

ANGO News

More News